After our CLM findings that 95% of people living with HIV (PLHIV) are not aware of the India HIV/AIDS Act 2017, we organized different sensitization workshops among PLHIV along with the State Ombudsman for HIV which established under the Act. Post these workshops, during August and September 2024, we received four (4) complaints from individuals […]
Tag: advogains
People who use drugs and CLM assisting completion of care cascade.
During August and September 2024, we identified nine care recipients with a history of drug use who had completed their hepatitis C treatment at Model Treatment Centres of Regional Institute of Medical Sciences (RIMS) and Jawaharlal Nehru Institute of Medical Sciences (JNIMS). They had completed their treatment for hepatitis C more than a year ago […]
Successfully assisting for re-treatment of HCV
On 2nd of April 2024, we came across a person who use drugs who had completed his HCV treatment in November 2021with Sofosbuvir 400 mg & daclatasvir 60 mg for 12 weeks. Later he found that the treatment had failed while doing his SVR 12 test. But unfortunately, he was not really bothered about possible […]
Role of peer PWID in completing care and treatment cascade
During April 2024, we came across 4 care recipients who completed their HCV treatment at various timeframes. They all were unaware of the need for doing a SVR 12 test and processes of conducting the said test. Action taken: The care recipients requested CoNE team to help them for SVR test. Their blood samples were […]
HIV diagnosed & treatment initiated; HCV treatment after 20 years.
During April 2024, we interacted with a person who use who knew his HCV antibody status for 20 years. Due to ignorance and lack of knowledge about HCV he had not undergone HCV RNA test. After counselling and informed consent, his blood sample was taken and sent to a private laboratory to accelerate diagnosis process. […]
Peer PWID filling the gap of viral hepatitis awareness
During March 2024, we interviewed a person who has not done his HCV RNA test after being HCV antibody reactive two years ago. He was not aware of the HCV services available under the National Viral Hepatitis Control Program. Action Taken: Our data enumerators provided him with counselling about the interpretation of HCV antibody reactive result and […]
Implementation guidelines for Community-led monitoring (CLM) of hepatitis B and C services in Indonesia
The Indonesian Directorate General of Prevention and Control of Infectious Diseases, Ministry of Health in collaboration with Peduli Hati Bangsa, Jakarta has developed “Implementation guidelines for Community-led monitoring (CLM) of hepatitis B and C services in Indonesia”. This is the first national program adoption of indicators developed by community groups on hepatitis B and C. […]
Completing hepatitis C treatment cascade is still a challenge
During March, we interacted with a respondent who had completed re- treatment of his hepatitis C infection with Sofosbuvir/ velpatasvir for 12 weeks in 2023. But due to his frequent relapse to drug use he has not been able to conduct his sustained virologic response (SVR) test to ascertain if he has been cured form […]
HIV treatment re-initiated, hepatitis B status completely informed and hepatitis C treatment initiated
During February in a voluntary drug treatment program, we interacted with a street-based person who use drugs who shared having stopped his HIV related anti- retroviral treatment for the last one year which he attributed to his drug use habits. The data enumerators, upon counselling also provided screening for hepatitis B surface antigen (HBsAg) and […]
Using drugs doesn’t mean cannot be on treatment for HCV
During February 2024, a care recipient informed of having known to be HCV RNA positive, but due to his drug use behavior he couldn’t initiate treatment. The data enumerators provided the care recipient with required pre-treatment counseling and the importance of early diagnosis and treatment. His family supported the pre-treatment test, required by government guidelines, […]